... The most commonly used drugs are vorinostat (Zolinza) and romidepsin (Istodax). Both are given intravenously. One MyLymphomaTeam member described a family member’s treatment with romidepsin, “She went for her initial treatment last Thursday and it seems to be working. Her itching has subsided significantly. ...
... The most commonly used drugs are vorinostat (Zolinza) and romidepsin (Istodax). Both are given intravenously. One MyLymphomaTeam member described a family member’s treatment with romidepsin, “She went for her initial treatment last Thursday and it seems to be working. Her itching has subsided significantly. ...
... A stem cell transplant can decrease the chance of relapse after initial treatment.Targeted TherapyTreatment for AITL that is relapsed or refractory (unresponsive to standard chemotherapy) may be treated using targeted drug therapy with the histone deacetylase inhibitors Istodax (romidepsin) or Beleodaq (belinostat). ...
... A stem cell transplant can decrease the chance of relapse after initial treatment.Targeted TherapyTreatment for AITL that is relapsed or refractory (unresponsive to standard chemotherapy) may be treated using targeted drug therapy with the histone deacetylase inhibitors Istodax (romidepsin) or Beleodaq (belinostat). ...
... Examples include belinostat (Beleodaq), romidepsin (Istodax), and vorinostat (Zolinza).Phosphatidylinositol 3-kinase InhibitorsPhosphatidylinositol 3-kinases (PI3Ks) are a group of proteins that contribute to cell growth and survival. PI3K inhibitors can be used as second-line treatments for people with follicular lymphoma and CLL/SLL. ...
... Examples include belinostat (Beleodaq), romidepsin (Istodax), and vorinostat (Zolinza).Phosphatidylinositol 3-kinase InhibitorsPhosphatidylinositol 3-kinases (PI3Ks) are a group of proteins that contribute to cell growth and survival. PI3K inhibitors can be used as second-line treatments for people with follicular lymphoma and CLL/SLL. ...